Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2012, Vol. 32 Issue (09): 48-54    
技术与方法     
shRNA随机文库结合TK自杀基因筛选靶向HIV-1LTR相关宿主因子
李建彬1,2, 米志强1, 安小平1, 谭莉1, 陈斌1, 王晓娜1, 范华昊1, 张文慧1, 张博1, 方祥2, 童贻刚1
1. 军事医学科学院微生物流行病研究所 病原微生物生物安全国家重点实验室 北京 100071;
2. 华南农业大学食品学院 广州 510642
Random shRNA Library Screen for shRNAs Targeting HIV-1 LTR Related Host Factors with TK Suicide Gene
LI Jian-bin1,2, MI Zhi-qiang1, AN Xiao-ping1, TAN Li1, CHEN Bin1, WANG Xiao-na1, FAN Hua-hao1, ZHANG Wen-hui1, ZHANG Bo1, FANG Xiang2, TONG Yi-gang 1
1. State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Science, Beijing 100071, China;
2. College of Food Science, South China Agricultural University, Guangzhou 510642, China
 全文: PDF(601 KB)   HTML
摘要: 构建shRNA随机文库与HIV-1 LTR启动胸苷激酶基因(TK基因)稳定表达的稳定细胞系HEK293/TK,将两者结合起来,筛选靶向HIV-1 LTR相关宿主因子。方法:通过化学合成含有19个随机脱氧核苷酸的发夹结构,将其退火补平后与合成的接头Linker连接进行PCR反应,将PCR产物酶切后置于慢病毒载体pLenti-U6启动子下游由此构建shRNA随机文库;利用重叠PCR将HIV-1 LTR片段和TK基因连接起来,连接产物经酶切后与pcDNA3.1载体连接;将连接正确的质粒转染HEK293细胞同时用G418加压筛选获得稳定细胞系HEK293/TK;将所获得的文库质粒包装成慢病毒后侵染所构建的HEK293/TK细胞系,通过加入药物GCV进行加压筛选获得存活细胞。结果:成功筛选到加药后存活下来的细胞,抽提细胞基因组,采用巢式PCR扩增目的干扰序列并用Western blot对干扰序列进行验证,鉴定获得一个克隆所表达的shRNA能对TK基因的表达起到抑制作用,通过测序分析获得其干扰序列,该序列很有可能针对HIV-1 LTR某宿主相关因子。结论:成功构建了一种筛选HIV-1 LTR相关宿主因子的方法,筛选所得序列可以定位到具体相关宿主因子,为靶向筛选抗HIV-1药物提供了重要手段。
关键词: 慢病毒载体shRNA随机文库人类免疫缺陷病毒(HIV-1)末端重复序列(LTR)TK自杀基因    
Abstract: To screen HIV-1 LTR related host factors by constructing random RNAi library based on the lentiviral vector and HIV-1 LTR reporter cell line in which TK suicide gene can express stably. Methods: Oligo deoxynucleotides were chemically synthesized which formed hairpin structure that contain 19 random bases and were then fused with a linker sequence. The joined product was amplified by PCR and the PCR product was cloned downstream of U6 promoter of a lentiviral vector pLenti-U6 to prepare random shRNA Library. HIV-1 LTR and HSV-TK gene were amplified by PCR and then joined by overlapping PCR. The joined product was cloned into pcDNA3.1 expression vector. The recombinant plasmid obtained was transfected into HEK293 cells, and stable cell lines were selected with G418. Lentiviral particles were pachaged in 293FT cells by transfection with random shRNA library plasmid along with pLP1, pLP2 and VSV-G, using Lipofectamine 2000. HEK293/TK cells were plated and infected with enriched random lentivirus shRNA library and then treated by GCV. Results: The surviving cells were collected after about two months, and genomic DNAs were extracted from the surviving cells to amplify integrated shRNAs by nested PCR. After verifying the validity of the interference sequence by Western blotting, a clone was isolated that expressed shRNA which inhibited the expression of TK gene. The shRNA sequence was determined by sequencing, and this sequence is likely to inhibit a host factor required for HIV-1 LTR function. Conclusion: By this strategy, it is possible to identify host factors assistant HIV-1 LTR, which could be potential host cellular targets for preparing novel anti-HIV drug.
Key words: Lentiviral vector    Random shRNA library    HIV-1    LTR    TK suicide gene
收稿日期: 2012-04-09 出版日期: 2012-09-25
ZTFLH:  Q786  
通讯作者: 童贻刚     E-mail: tong62035@gmail.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
李建彬
米志强
安小平
谭莉
陈斌
王晓娜
范华昊
张文慧
张博
方祥
童贻刚

引用本文:

李建彬, 米志强, 安小平, 谭莉, 陈斌, 王晓娜, 范华昊, 张文慧, 张博, 方祥, 童贻刚. shRNA随机文库结合TK自杀基因筛选靶向HIV-1LTR相关宿主因子[J]. 中国生物工程杂志, 2012, 32(09): 48-54.

LI Jian-bin, MI Zhi-qiang, AN Xiao-ping, TAN Li, CHEN Bin, WANG Xiao-na, FAN Hua-hao, ZHANG Wen-hui, ZHANG Bo, FANG Xiang, TONG Yi-gang. Random shRNA Library Screen for shRNAs Targeting HIV-1 LTR Related Host Factors with TK Suicide Gene. China Biotechnology, 2012, 32(09): 48-54.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/        https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I09/48

[1] Kilareski E, Shah S, Nounemaeher M R. Regulation of HIV-l transcription in cells of the monocyte-macrophage lineage. Retrovirology, 2009,6:118.
[2] Gao Y. A way leading to an effective anti-HIV Vaccine. Anti Infect Pharm, 2011,8(1):2.
[3] Garber D A, Silvestri G, Feinberg M B. Prospects for an AIDS vaccine: three big questions, no easy answers. The Lancet Infectious Diseases, 2004,4(7):397-413.
[4] Guo Z M, Chen H S. HIV-1 Integrase:The next target for AIDS treatment. Foreign Med Sci (Virology Lemol), 2001,8(2):43-48.
[5] Shafer R W, Schapiro J M. HIV-l drug resistance mutations:an updated frame work for the Second decade of HAART. AIDS Rev, 2008,10(2):67-84.
[6] Tang J W, Pillay D. Transmission of HIV-1 drug resistance. J Clin Virol, 2004,30(1):1-10.
[7] 郜瑞,赵霞霞,李发荣. 药物靶标发现的技术. 药物生物技术,2009,16(1):90-94. Gao R, Zhao X X, Li F R. Method of drug target discovery.Pharmaceutical Biotechnology, 2009,16(1):90-94.
[8] Reynolds L, Ullman C, Moore M, et al. Repression of the HIV-1 5’LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. PNAS, 2002,100(4):1615-1620.
[9] Moffat J, Grueneberg D A, Yang X, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell, 2006,124(6):1283-1298.
[10] Llanos S, Efeyan A, Monsech J, et al. A high-throughput loss-of-function screening identifies novel p53 regulators. Cell Cycle, 2006,5(16):1880-1885.
[11] Supekova L, Supek F, Lee J, et al. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J Biol Chem, 2008,283(1):29-36.
[12] Du C, Ge B, Liu Z, et al. PCR-based generation of shRNA libraries from cDNAs. BMC Biotechnol, 2006,6:28.
[13] Guo Q, Kong Y, Fu L, et al. A randomized lentivirus shRNA library construction. Biochem Biophys Res Commun, 2007,358(1):272-276.
[14] 孙瑞元. 定量药理学. 北京:人民卫生出版社,1987.155-161. Sun R Y. Quantitative Pharmacology. Beijing: People’s Medical Press, 1987.155-161.
[15] Patil R, Chavez J B, Yee D. Inducible expression of herpes simplex virus thymidine kinase increases sensitivity to ganciclovir but does not enhance bystander effect in breast cancer cells. Breast Cancer Res Treat, 2000,62(2):109-115.
[16] 陈平,孙振华. 自杀基因治疗肿瘤的现状与展望. 实用临床医药杂志,2006,10(4):128-131. Chen P, Sun Z H. Current status and perspective of curing cancer with TK suicide gene. Modern Medicine Journal of China, 2006,10(4): 128-131.
[17] Jaffrelo L, Chabas S, Reigadas S, et al. A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors. Nucleic Acids Res, 2008,36(15):e95.
[1] 赵晓煜,徐祺玲,赵晓东,安云飞. 基因治疗慢病毒载体的转导增强策略*[J]. 中国生物工程杂志, 2021, 41(8): 52-58.
[2] 韩亚丽,杨冠恒,陈雁雯,龚秀丽,张敬之. 表达β-珠蛋白基因的安全性慢病毒载体的优化 *[J]. 中国生物工程杂志, 2018, 38(7): 50-57.
[3] 高越, 檀硕, 任兆瑞, 张敬之. 原位染色检测慢病毒载体转录通读方法的建立[J]. 中国生物工程杂志, 2015, 35(5): 55-60.
[4] 李玉强, 朱志图, 王巍, 李谌, 徐娜, 王钰, 李男, 孙宏治. RNA干扰NUP88基因对人乳腺癌MCF-7细胞生长及侵袭力的影响[J]. 中国生物工程杂志, 2014, 34(9): 31-39.
[5] 王鑫, 陈玲, 孙飞, 陆航. RNAi沉默CXCR7对人结肠癌细胞SW620特异性靶向抑制的实验研究[J]. 中国生物工程杂志, 2014, 34(2): 14-20.
[6] 管洁, 邓瑶, 文波, 陈红, 王文, 谭文杰. 整合缺陷型重组慢病毒载体构建及HCV重组假型慢病毒颗粒的制备与性状分析[J]. 中国生物工程杂志, 2013, 33(6): 62-67.
[7] 李袁飞, 赵和平, 刘静, 朱国强, 张革红, 贾军梅, 杨文慧. 在结肠癌细胞中RNA干扰TGFBR2慢病毒载体的构建及其功能的初步研究[J]. 中国生物工程杂志, 2013, 33(5): 28-34.
[8] 燕海峰, 易康乐, TREFIL P, 胡雄贵, 邓缘, 朱立军. 慢病毒载体导入种蛋内鸡胚技术研究[J]. 中国生物工程杂志, 2012, 32(12): 73-79.
[9] 石永乾, 何文腾, 周洋, 焦明霞, 解炳腾, 胡魁, 孔庆然, 刘忠华. 慢病毒载体介导的绿色荧光蛋白转基因标记法研究猪嵌合体制作[J]. 中国生物工程杂志, 2012, 32(08): 68-74.
[10] 钟艳平, 林若芸, 黎丹戎, 胡晓霞, 王琪, 李力. hTERT重组第三代慢病毒载体的构建及其病毒包装鉴定[J]. 中国生物工程杂志, 2011, 31(9): 21-27.
[11] 陈斌, 李建彬, 米志强, 安小平, 李存, 刘大斌, 姜焕焕, 王娟, 黄芬, 张宝中, 范华昊, 何后军, 童贻刚. 利用移码突变和终止密码子提高下游目的基因的表达水平[J]. 中国生物工程杂志, 2011, 31(8): 92-96.
[12] 王丽娴, 王东阳, 李星, 夏海滨. 携带三种报告基因慢病毒载体的构建及其实验研究[J]. 中国生物工程杂志, 2011, 31(12): 86-92.
[13] 刘丹如,宋长征,张更林,杜国利. 重组HIV-1壳体蛋白在转基因枸杞根系中的分泌表达[J]. 中国生物工程杂志, 2007, 27(2): 53-57.
[14] 王淑艳,张愚. 慢病毒载体的设计及应用进展[J]. 中国生物工程杂志, 2006, 26(11): 70-75.
[15] 邓继先, 沈伟. 用慢病毒载体制备转基因动物的研究进展[J]. 中国生物工程杂志, 2004, 24(9): 16-20.